VBL Therapeutics Announces First Quarter 2017 Financial Results

TEL AVIV, Israel, May 15, 2017 (GLOBE NEWSWIRE) — VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, announced financial results for the first quarter ended March 31, 2017, as well as a corporate update.